Fetal Intervention for Congenital Diaphragmatic Hernia
sciencedirect.com shows its articles on its own site.
Read the article on sciencedirect.com ↗Article · Aug 2019 · 1 min read
In brief
In brief
Review of fetal intervention for congenital diaphragmatic hernia (CDH), focusing on Fetoscopic Endoluminal Tracheal Occlusion (FETO) as the current standard technique. Covers patient selection criteria, surgical approach, and early outcomes for high-risk CDH cases where pulmonary hypoplasia threatens neonatal survival.
Written by the GCMD Library team from the article.
Publication date: Available online 18 July 2019
Source: Seminars in Pediatric Surgery
Author(s): Mark L. Kovler, Eric B. Jelin
Abstract
Congenital diaphragmatic hernia (CDH) is a condition that results from incomplete diaphragm formation during embryogenesis. The diaphragmatic defect allows for herniation of abdominal viscera into the chest, and the resulting pulmonary hypoplasia and pulmonary hypertension can lead to cardiorespiratory failure in the neonatal period. There is a wide spectrum of disease severity in CDH, and while advances in neonatal care and the introduction of extracorporeal membrane oxygenation have improved outcomes in many cases, the most severe defects are still associated with high morbidity and mortality. Improvements in prenatal diagnostic and prognostic capabilities have created an opportunity to select high risk patients for fetal intervention. Three decades of refinements in the fetal surgical therapy for CDH have led to the current technique of Fetoscopic Endoluminal Tracheal Occlusion (FETO). Herein, we review the current considerations for selecting patients for fetal intervention, and the contemporary fetal surgical operation for CDH, FETO, with a focus on early outcomes and ongoing studies.
